Here's why the Incannex (ASX:IHL) share price has rocketed 60% in a month

A raft of company and regulatory catalysts have propped up the Incannex share price over the past few weeks.

| More on:
A woman jumps for joy with a rocket drawn on the wall behind her.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in medicinal cannabis company Incannex Healthcare Ltd (ASX: IHL) are edging lower and now trade at 57.5 cents.

The Incannex Healthcare share price opened at 60 cents before reversing within minutes to bounce off a low of 56.5 cents.

Despite this, Incannex shares have outperformed this past month, having piled on another 60% in that time.

That's well ahead of the S&P/ASX 200 Health Care Index (ASX: XHJ), which has jumped 3.4% in a month, whereas the benchmark S&P/ASX 200 Index (ASX: XJO) is up 1.48%.

Here are the details.

What's up with the Incannex Healthcare share price lately?

Incannex's share price hit its 52-week high in early trade today as investors continue piling into the company.

A raft of company and regulatory catalysts have propped up the Incannex share price over the past few weeks.

For instance, the company recently advised an ethics committee had approved its Phase 2a clinical trial investigating the efficacy of psilocybin for any primary anxiety disorder.

The trial is the first in the world to examine the safety and efficacy of this compound. Psilocybin is the psychoactive component of 'magic mushrooms'.

Psychedelic medicine has been gaining traction in psychotherapy and psychiatry circles lately. This has brought about a number of clinical breakthroughs to complex mental conditions.

An ethics committee approving the trial is "an exciting step for Incannex… and for the emerging field of psychedelic medicine," according to the doctor leading the study.

The company also released its quarterly report to finish October, where it outlined several investment highlights.

One key takeout was the company successfully raising $17.66 million from an option exercise program. This includes $8.2 million from its chief medical officer, Dr Sud Agarwal.

What else is playing a part?

In addition, Incannex recently engaged drug manufacturing company Procaps S.A. to develop soft gel capsules for its proprietary IHL-42X label.

Specifically, IHL-42X is indicated in the treatment of obstructive sleep apnoea (OSA).

OSA is a prevalent condition that has implications for mental, cardiovascular and physical health. Incannex is seeking to find a remedial breakthrough in this condition as well.

According to the company, Procaps has assisted in developing over 500 pharmaceutical and nutritional products in over 50 global markets.

It will now manufacture the capsules for Incannex's IHL-42X cannabinoid product for use in pivotal Phase 2 and 3 trials.

Aside from this, Incannex also confirmed the recent success of its IHL-65A label in reducing inflammatory conditions such as rheumatoid arthritis.

The company showed data that its compound was up to 3.5x more effective at reducing symptoms associated with rheumatoid arthritis than conventional treatments.

Separately, the company also filed for F-1 registration to list its shares on the United States NASDAQ exchange earlier this year.

An F-1 is basically the same as an initial public offering (IPO) on the ASX. However, it is reserved for non-US companies who wish to list on an American exchange.

Incannex is proposing a public offering of American Depositary Shares (ADS) with each ADS representing 50 ordinary shares in the company.

Incannex Healthcare share price snapshot

The Incannex Healthcare share price has been one to watch these past 12 months. Incannex shares have rallied as much as 524% in that time.

This has come after it has gained another 274% this year to date. That's well ahead of the broad indices and the benchmark's returns, 11% and 13% respectively.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson

More on 52-Week Highs

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

12 ASX 200 shares that smashed historical peak prices today

Twelve ASX 200 shares rose to new multi-year peaks in an otherwise quiet day of trading.

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

8 ASX 200 stocks striking multi-year highs today

These shares hit new price milestones amid a day in the green for the ASX 200.

Read more »

Five businessmen in suits walking up stairs in neat succession.
52-Week Highs

5 ASX 200 shares smashing new 52-week highs today

These five ASX 200 shares just broke into new multi-year and all-time highs. Here’s why.

Read more »

A mother and her young son are lying on the floor of their lounge sharing a tech device.
Technology Shares

Life360 shares are up more than 1,300% in 5 years. How does it compare to other apps?

Can Life360 compete with the likes of Facebook and Instagram?

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
52-Week Highs

5 ASX 200 shares hitting multi-year highs after strongly rebounding from tariff turmoil

These stocks have hit new price milestones amid a day in the green for the ASX 200.

Read more »

Woman laying with $100 notes around her, symbolising dividends.
52-Week Highs

Which ASX All Ords stock recently became a 10-bagger in 5 years?

Landing a 10-bagger is every investor's dream.

Read more »

Five happy friends enjoying a party.
52-Week Highs

5 ASX 200 shares smashing new 52-week highs today

The Trump tariff relief rally has helped send these five ASX 200 shares to new 52-week highs.

Read more »

Arrows pointing upwards with a man pointing his finger at one.
52-Week Highs

3 ASX All Ords shares at new 52-week highs this Friday

These shares are proving to be a safe harbour this Friday.

Read more »